Federated Hermes Inc. Sells 1,533 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Federated Hermes Inc. decreased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 55,009 shares of the company’s stock after selling 1,533 shares during the quarter. […]

Related Keywords

United States ,Wellington ,New Zealand General ,New Zealand , ,Goldman Sachs Group ,Qube Research Technologies Ltd ,Invesco Ltd ,Nasdaq ,Wellington Management Group ,Deutsche Bank ,Genetics Inc ,Jump Financial ,Hermes Inc ,Exchange Commission ,Federated Hermes ,Myriad Genetics ,Free Report ,Management Group ,Technologies Ltd ,Genetics Stock Down ,Get Free Report ,Myrisk Hereditary Cancer Test ,Germline Companion Diagnostic Test ,Companion Diagnostic Test ,Visit Holdingschannel ,Myriad Genetics Daily ,Nasdaq Mygn ,Mygn ,Medical ,62855j10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,